Role of Intravenous Nitroglycerin in Resistant Hypertension

Mechanism of Action and Hemodynamic Effects

• The American College of Cardiology states that nitroglycerin causes decreased venous return (preload reduction) and reduced systemic vascular resistance (afterload reduction) 1

Indications for Intravenous Nitroglycerin in Hypertension

• The American Heart Association, as published in Circulation, indicates that intravenous nitroglycerin is used for hypertension with acute coronary syndromes or angina not responsive to sublingual nitroglycerin 2
• The American College of Cardiology recommends intravenous nitroglycerin for hypertension with pulmonary congestion or heart failure 1

Administration Protocol

• The American College of Cardiology suggests an initial dosing of 5-10 mcg/min via continuous IV infusion using non-absorbing tubing 3
• The American College of Cardiology recommends titration by increasing the dose by 5-10 mcg/min every 3-5 minutes until the desired response is observed 5

Blood Pressure Targets and Monitoring

• The American College of Cardiology advises that systolic blood pressure should generally not be titrated below 110 mmHg in previously normotensive patients 5
• The American College of Cardiology recommends avoiding reduction of mean arterial pressure by more than 25% below baseline in the initial treatment period 5

Contraindications and Precautions

• The American College of Cardiology warns against using nitroglycerin in patients with initial systolic blood pressure less than 90 mmHg 5
• The American College of Cardiology advises against using nitroglycerin in patients with recent use of phosphodiesterase inhibitors (sildenafil within 24h, tadalafil within 48h) 3

Adverse Effects and Management

• The American College of Cardiology notes that common adverse effects of nitroglycerin include headache, hypotension, and reflex tachycardia 3
• The American College of Cardiology states that tachyphylaxis (tolerance) typically develops after 24 hours of continuous therapy 1

Comparison with Other Agents for Resistant Hypertension

• The American Heart Association, as published in Circulation, suggests that sodium nitroprusside offers more potent and reliable blood pressure reduction for pure resistant hypertension without cardiac indications 6